Particle.news
Download on the App Store
39 ARTICLES
·
3w ago

Preliminary Tests Detect Botulism Bacterium in Recalled ByHeart Infant Formula

Regulators are conducting confirmatory tests on leftover cans, with results expected in the coming weeks.

Image
FILE - The Food and Drug Administration seal is seen at the Hubert Humphrey Building Auditorium in Washington, April 22, 2025. (AP Photo/Jose Luis Magana, File)
Image
Yury Navas, 29, of Laurel, Md., kisses her two-month-old baby Jose Ismael Gálvez, at Superbest International Market in Laurel, Md., May 23, 2022, while looking for formula. (AP Photo/Jacquelyn Martin, file)

Overview

  • Thirteen infants in 10 states were hospitalized after reportedly consuming ByHeart Whole Nutrition Infant Formula, and no deaths have been reported.
  • ByHeart voluntarily recalled two lots — 206VABP/251261P2 and 206VABP/251131P2 — each marked “Use by 01 Dec 2026.”
  • California’s public‑health lab reported preliminary results suggesting the presence of Clostridium botulinum in a tested sample of the product.
  • The FDA says no definitive direct link between infant formula and the cases has been established and officials are tracing exposures and the point of contamination.
  • Parents are urged to stop using the recalled cans, clean any items that contacted the formula, monitor infants for symptoms, and note that treatment is available; the affected brand accounts for about 1% of U.S. formula sales, so shortages are not expected.